August 26, 2020
Bayer, the maker of the female sterilization device Essure, announced last week that it would pay about $1.6 billion to resolve approximately 90% of the nearly 39,000 U.S. Essure claims involving women who allegedly suffered injuries caused by the controversial birth control device. The German medical device… Read More> Comments Off on Bayer Agrees to Settle Essure Injury Lawsuits for $1.6 Billion
June 26, 2020
Bayer, the maker of the highly controversial Roundup weed killer, has announced a plan to settle most of the Roundup cancer lawsuits currently pending against the company, as well as possible future claims, for more than $10 billion. The announcement came on June 24, 2020, after… Read More> Comments Off on Bayer Will Pay $10 Billion to Resolve Tens of Thousands of Roundup Cancer Claims
June 23, 2020
Significant new safety warnings have been added to the label for Elmiron, a medication commonly prescribed to treat pain and discomfort associated with a bladder condition called interstitial cystitis (IC). On June 16, 2020, for the first time since Elmiron’s introduction in 1996, manufacturer Janssen Pharmaceuticals warned… Read More> Comments Off on Major Elmiron Warning Label Update Highlights Risk of Retinal Damage Side Effects
June 4, 2020
The surviving family member of a Pennsylvania man who died from pancreatic cancer last year has filed a wrongful death lawsuit against the makers of Zantac, alleging that years of exposure to carcinogenic chemicals in the recalled heartburn drug caused her loved one’s death. The Zantac wrongful… Read More> Comments Off on Family Sues Zantac Makers Over Fatal Case of Pancreatic Cancer
May 22, 2020
Faced with nearly 20,000 lawsuits involving talcum powder cancer claims, Johnson & Johnson announced this week that it will no longer sell talc-based Baby Powder, a product that has been a hallmark of the company for more than a century. Since 1894, Johnson & Johnson has marketed… Read More> Comments Off on J&J Discontinues Talc-Based Baby Powder Amid Nearly 20,000 Cancer Claims
May 14, 2020
The federal judge overseeing the Zantac multidistrict litigation (MDL) has chosen more than two dozen plaintiffs’ attorneys to serve in leadership positions in the growing litigation over the recalled heartburn drug Zantac and its potential to cause cancer in users. After interviewing 62 attorneys involved in the… Read More> Comments Off on Federal Judge Assigns More Than Two Dozen Attorneys to Leadership Positions in Zantac Cancer MDL
May 13, 2020
A California appeals court has reinstated the eligibility of thousands of cases against Johnson & Johnson and its Janssen Pharmaceuticals subsidiary, alleging that the company’s antipsychotic drug Risperdal causes abnormal breast growth in males. The court ruling reverses a lower court’s decision to grant Johnson & Johnson’s… Read More> Comments Off on Appeals Court Reinstates Risperdal Gynecomastia Claims Against Johnson & Johnson
